FindTrial
Sign In

Phenelzine Sulfate

DRUG4 trials

Sponsors

OHSU Knight Cancer Institute, University of Southern California, EpiAxis Therapeutics, Boehringer Ingelheim

Conditions

Adenocarcinoma of the ProstateHealthyHormone-Resistant Prostate CancerMetastatic Breast CancerMetastatic Prostatic AdenocarcinomaProstate AdenocarcinomaRecurrent Prostate CancerRecurrent Prostate Carcinoma

Phase 1

An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer
CompletedNCT03505528
EpiAxis TherapeuticsMetastatic Breast Cancer
Start: 2017-08-17End: 2019-10-30Updated: 2019-11-13
A Study in Healthy People to Test How Combining BI 1467335 and Tyramine Affects Blood Pressure
TerminatedNCT03979820
Boehringer IngelheimHealthy
Start: 2019-07-31End: 2020-04-08Updated: 2021-06-04

Phase 2

Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
TerminatedNCT01253642
OHSU Knight Cancer InstituteHormone-Resistant Prostate Cancer, Metastatic Prostatic Adenocarcinoma, Prostate Adenocarcinoma +1
Start: 2010-07-12End: 2017-09-15Updated: 2019-10-02
Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer
CompletedNCT02217709
University of Southern CaliforniaAdenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IIA Prostate Cancer +3
Start: 2014-09-08End: 2020-06-29Updated: 2022-12-12

Related Papers

Abstract LB259: Development of a CTC based assay to characterize MAOA expression in metastatic prostate cancer
Cancer Research2025-04-25
A Phase 1 Proof of Concept Study Evaluating the Addition of an LSD1 Inhibitor to Nab-Paclitaxel in Advanced or Metastatic Breast Cancer (EPI-PRIMED)
Frontiers in Oncology2022-06-0317 citations
Phase II trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer.
Journal of Clinical Oncology2020-02-193 citations